ConductScience.org, home

Paper37586453

Protection against cancer therapy-induced cardiovascular injury by planed-derived polyphenols and nanomaterials.

Liao Y and 1 other. Environ Res, 2023. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Protection against cancer therapy-induced cardiovascular injury by planed-derived polyphenols and nanomaterials. Papers, record 37586453. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37586453

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Protection against cancer therapy-induced cardiovascular injury by planed-derived polyphenols and nanomaterials.
PubMed
Journal
Environ Res
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
1.61
iCite
Revised in PubMed
2023-11-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liao YYunshu
2Meng QQinghua

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
NanoparticlesMajor topic
Cardiovascular DiseasesMajor topic
Heart InjuriesMajor topic
Humans
Polyphenols
Antioxidants
Anti-Inflammatory Agents

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42794525Cardioprotective Potential of Grape-Derived Polyphenols in Cancer Therapy-Related Cardiotoxicity.Int J Mol Sci2026https://conductscience.org/library/papers/42794525PubMed
41937498Gene Expression Alterations Associated With Resveratrol-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Osteosarcoma Cancer Cells.J Cell Mol Med2026https://conductscience.org/library/papers/41937498PubMed
41697297Potent anticancer activity of phenolic-enriched extracts from endemic plants supported by in vitro pharmacological analyses and in silico molecular docking.Naturwissenschaften2026https://conductscience.org/library/papers/41697297PubMed
40439873Radiation-Induced Cardiac Remodeling: Mechanisms and Therapeutic Approaches.Cardiovasc Toxicol2025https://conductscience.org/library/papers/40439873PubMed
40009315Doxorubicin-Induced Cardiac Remodeling: Mechanisms and Mitigation Strategies.Cardiovasc Drugs Ther2026https://conductscience.org/library/papers/40009315PubMed
39397196Potential Player of Platelet in the Pathogenesis of Cardiotoxicity: Molecular Insight and Future Perspective.Cardiovasc Toxicol2024https://conductscience.org/library/papers/39397196PubMed
38984581Radiotherapy Enhancing and Radioprotective Properties of Berberine: A Systematic Review.Recent Pat Anticancer Drug Discov2025https://conductscience.org/library/papers/38984581PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37586453

GET https://conductscience.org/api/papers/v1/37586453/authors